🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to assess whether adding modified-re...
Status
Completed
Location
9.169.01 Dept of Clinical Pharmacology
Start Date
2004-04-01
Trial ID
NCT00129038
Treatments Being Tested
Early-onset preeclampsia (PE), defined as preeclampsia presenting before 34...
Status
Not Yet Recruiting
Location
Hadassah University Medical Center
Start Date
2026-09
Trial ID
NCT07738562
Treatments Being Tested
The risk of recurrence is greatest immediately after stroke or Transient Is...
Status
Terminated
Location
Nottingham University Hospitals NHS Trust
Start Date
2009-04
Trial ID
NCT01661322
Treatments Being Tested
A Phase 2 multi-center, assessor-blind, randomized study to assess the safe...
Status
Terminated
Location
RIMS - Government Medical College
Start Date
2022-02-01
Trial ID
NCT05166876
Treatments Being Tested
To compare the combination of acetylsalicylic acid (25 mg) + modified-relea...
Status
Completed
Location
Multiple Locations
Start Date
2000-01
Trial ID
NCT02268773
Treatments Being Tested
The primary goal is to determine if Dipyridamole can improve serum phosphat...
Status
Recruiting
Location
Stanford University
Start Date
2025-05-15
Trial ID
NCT06824454
Treatments Being Tested
To investigate the relative bioavailability of the proposed formulation of ...
Status
Completed
Location
Multiple Locations
Start Date
2001-10
Trial ID
NCT02259998
Treatments Being Tested
There is a marked lack of evidence on the optimal prevention of ischaemic s...
Status
Completed
Location
Amsterdam UMC
Start Date
2014-09
Trial ID
NCT02565693
Treatments Being Tested
The purpose of the trial is to determine if extended-release dipyridamole +...
Status
Completed
Location
9.159.1101 Boehringer Ingelheim Investigational Site
Start Date
2003-08
Trial ID
NCT00153062
This study is a multicenter, prospective, open-label, endpoint-blinded, ran...
Status
Recruiting
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2024-10-18
Trial ID
NCT06899399
Treatments Being Tested